Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-22-003108
Filing Date
2022-08-15
Accepted
2022-08-15 16:07:03
Documents
5
Effectiveness Date
2022-08-15

Document Format Files

Seq Description Document Type Size
1 S-8 zk2228346.htm S-8 99977
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9852
3 EXHIBIT 23.1 exhibit_23-1.htm EX-23.1 2497
4 EXHIBIT 107.1 exhibit_107-1.htm EX-FILING FEES 14794
5 image00003.jpg GRAPHIC 14089
  Complete submission text file 0001178913-22-003108.txt   147794
Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002
Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156
Chemomab Therapeutics Ltd. (Filer) CIK: 0001534248 (see all company filings)

EIN.: 813676773 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266868 | Film No.: 221165661
SIC: 2834 Pharmaceutical Preparations